Healthcare & Life Sciences
X-Cell Medical
United States
seed
seed
Stage
1
Investors
About
X-Cell Medical develops integrated drug-eluting stents that use 17-β-estradiol to enhance endothelial growth, aiming to treat restenosis and reduce sub-acute thrombosis in cardiovascular applications.
Explore X-Cell Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.